Drugmaker Novo Nordisk profits jump in diabetes scourge
Danish drugmaker Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.
May 2, 2018
0
4